3rd Quarter - Amendment

THE STRATEGY GROUP, INC. for PHRMA

Firm
Client
Income
$10,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 13, 2015 $10,000 Replaced
3rd Quarter - Amendment (this page) Oct 16, 2015 $10,000 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

340B Pharmacy Program.

LobbyistCovered position, as disclosed
KATHLEEN VIRGINIA KELLY —
DAVID NEWMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medical/Disease Research/Clinical Labs MED

NIH Funding

LobbyistCovered position, as disclosed
KATHLEEN VIRGINIA KELLY —
DAVID NEWMAN —
SUSAN TRACY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Medicare Part D and the Independent Payment Advisory Board

LobbyistCovered position, as disclosed
KATHLEEN VIRGINIA KELLY —
DAVID NEWMAN —
SUSAN TRACY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Patent Reform, HR 9 The Innovation Act.

LobbyistCovered position, as disclosed
KATHLEEN VIRGINIA KELLY —
SUSAN TRACY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 9 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.